Yuan D, Xu W, Raza F, Zafar H, Guan S, Wang Z
Adv Pharmacol Pharm Sci. 2024; 2024:2869332.
PMID: 39624070
PMC: 11611450.
DOI: 10.1155/adpp/2869332.
Chu Buh F, Taiwe G, Kobeissy F, Wang K, Maas A, Motah M
NeuroSci. 2024; 4(3):164-177.
PMID: 39483201
PMC: 11523680.
DOI: 10.3390/neurosci4030015.
Mathew D, Purohit P, Gadwal A, Anil A, Kumar Sharma R, Meshram V
Int J Legal Med. 2024; 138(6):2559-2568.
PMID: 38977505
DOI: 10.1007/s00414-024-03287-z.
Mansour N, Elnaem M, Abdelaziz D, Barakat M, Dehele I, Elrggal M
Front Pharmacol. 2023; 14:1185277.
PMID: 37214454
PMC: 10196026.
DOI: 10.3389/fphar.2023.1185277.
Chen Y, Wang L, You W, Huang F, Jiang Y, Sun L
Front Neurol. 2022; 13:929386.
PMID: 36034283
PMC: 9402226.
DOI: 10.3389/fneur.2022.929386.
A Literature Review of Traumatic Brain Injury Biomarkers.
Ghaith H, Nawar A, Gabra M, Abdelrahman M, Nafady M, Bahbah E
Mol Neurobiol. 2022; 59(7):4141-4158.
PMID: 35499796
PMC: 9167167.
DOI: 10.1007/s12035-022-02822-6.
Selected Biomarkers of Tick-Borne Encephalitis: A Review.
Gudowska-Sawczuk M, Mroczko B
Int J Mol Sci. 2021; 22(19).
PMID: 34638953
PMC: 8509006.
DOI: 10.3390/ijms221910615.
[GCS score combined with CT score and serum S100B protein level Can evaluate severity and early prognosis of acute traumatic brain injury].
Yin W, Weng S, Lai S, Nie H
Nan Fang Yi Ke Da Xue Xue Bao. 2021; 41(4):543-548.
PMID: 33963713
PMC: 8110450.
DOI: 10.12122/j.issn.1673-4254.2021.04.09.
Circulating Cell-Free Nucleic Acids as Epigenetic Biomarkers in Precision Medicine.
Rahat B, Ali T, Sapehia D, Mahajan A, Kaur J
Front Genet. 2020; 11:844.
PMID: 32849827
PMC: 7431953.
DOI: 10.3389/fgene.2020.00844.
Blast-Related Traumatic Brain Injury: Current Concepts and Research Considerations.
Bryden D, Tilghman J, Hinds 2nd S
J Exp Neurosci. 2019; 13:1179069519872213.
PMID: 31548796
PMC: 6743194.
DOI: 10.1177/1179069519872213.
Neurochemical biomarkers in spinal cord injury.
Kwon B, Bloom O, Wanner I, Curt A, Schwab J, Fawcett J
Spinal Cord. 2019; 57(10):819-831.
PMID: 31273298
DOI: 10.1038/s41393-019-0319-8.
Leveraging the interplay of nanotechnology and neuroscience: Designing new avenues for treating central nervous system disorders.
Smith E, Porterfield J, Kannan R
Adv Drug Deliv Rev. 2019; 148:181-203.
PMID: 30844410
PMC: 7043366.
DOI: 10.1016/j.addr.2019.02.009.
Hyperbaric oxygen therapy attenuates neuronal apoptosis induced by traumatic brain injury via Akt/GSK3β/β-catenin pathway.
He H, Li X, He Y
Neuropsychiatr Dis Treat. 2019; 15:369-374.
PMID: 30774348
PMC: 6354685.
DOI: 10.2147/NDT.S183632.
Probability of Soluble Tissue Factor Release Lead to the Elevation of D-dimer as a Biomarker for Traumatic Brain Injury.
Suehiro E, Fujiyama Y, Kiyohira M, Motoki Y, Nojima J, Suzuki M
Neurol Med Chir (Tokyo). 2019; 59(2):63-67.
PMID: 30674749
PMC: 6375819.
DOI: 10.2176/nmc.oa.2018-0254.
Therapeutic hypothermia and targeted temperature management for traumatic brain injury: Experimental and clinical experience.
Dietrich W, Bramlett H
Brain Circ. 2018; 3(4):186-198.
PMID: 30276324
PMC: 6057704.
DOI: 10.4103/bc.bc_28_17.
Traumatic Brain Injury Altered Normal Brain Signaling Pathways: Implications for Novel Therapeutics Approaches.
Rana A, Singh S, Sharma R, Kumar A
Curr Neuropharmacol. 2018; 17(7):614-629.
PMID: 30207236
PMC: 6712292.
DOI: 10.2174/1570159X16666180911121847.
Protein biomarkers of epileptogenicity after traumatic brain injury.
Agoston D, Kamnaksh A
Neurobiol Dis. 2018; 123:59-68.
PMID: 30030023
PMC: 6800147.
DOI: 10.1016/j.nbd.2018.07.017.